John F. MacMaster
Impact in
- Cancer Research top 10%
- NF-κB Signaling Pathways
- Immunology top 10%
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Oncology 6
- Cytokine Signaling Pathways and Interactions 3
- Peptidase Inhibition and Analysis 1
-
- Enzyme function and inhibition 2
- Co-authors
- James R. Burke (4 shared papers)Philip M. Wallace (5 shared papers)Mark A. Pattoli (3 shared papers)Kurt R. Gregor (3 shared papers)Yuping Qiu (3 shared papers)F. Christopher Zusi (3 shared papers)Kim W. McIntyre (2 shared papers)Xiaoxia Yang (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (2 papers)Inflammation Research (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)The Journal of Immunology (1 paper)Toxicologic Pathology (1 paper)
- Partner nations
- United StatesGermanySweden
In The Last Decade
John F. MacMaster
12 papers receiving 973 citations
Peers
Comparison fields: 5 of 88
- Cancer Research 289
- Immunology 378
- Oncology 296
- Immunology and Allergy 39
- Molecular Biology 411
Countries citing papers authored by John F. MacMaster
This map shows the geographic impact of John F. MacMaster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John F. MacMaster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John F. MacMaster more than expected).
Fields of papers citing papers by John F. MacMaster
This network shows the impact of papers produced by John F. MacMaster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John F. MacMaster. The network helps show where John F. MacMaster may publish in the future.
Co-authors
The 25 scholars most cited alongside John F. MacMaster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 439 | |
| 2 | 1999 | 98 | |
| 3 | 1994 | 97 | |
| 4 | Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine. | 1994 | 68 |
| 5 | 2002 | 67 | |
| 6 | 2005 | 47 | |
| 7 | 2003 | 46 | |
| 8 | 2006 | 45 | |
| 9 | In vitro and in vivo activities of a doxorubicin prodrug in combination with monoclonal antibody beta-lactamase conjugates. | 1995 | 38 |
| 10 | 1995 | 31 | |
| 11 | 1999 | 16 | |
| 12 | 2003 | 1 | |
| 13 | The divine purpose of capital punishment. | 2010 | 0 |
About John F. MacMaster
John F. MacMaster is a scholar working on Oncology, Molecular Biology, Immunology, Cancer Research and Organic Chemistry, having authored 13 papers that have together received 993 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (4 papers), Cytokine Signaling Pathways and Interactions (3 papers), Enzyme function and inhibition (2 papers), Click Chemistry and Applications (2 papers), interferon and immune responses (1 paper), Peptidase Inhibition and Analysis (1 paper), Inflammatory Bowel Disease (1 paper) and Quinazolinone synthesis and applications (1 paper). The work is most often cited by research in Cancer Research (289 citations), Immunology (378 citations), Oncology (296 citations), Immunology and Allergy (39 citations) and Molecular Biology (411 citations). John F. MacMaster has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include James R. Burke, Philip M. Wallace, Mark A. Pattoli, Kurt R. Gregor, Yuping Qiu, F. Christopher Zusi, Kim W. McIntyre, Xiaoxia Yang, Joann Strnad and Wendy Clarke. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Inflammation Research, Journal of Pharmacology and Experimental Therapeutics, The Journal of Immunology and Toxicologic Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.